AIM announces Paul Goepfert, MD, as the principal investigator for th…AIM announces Paul Goepfert, MD, as the principal investigator for the... |
![]() AIM announces Paul Goepfert, MD, as the principal investigator for th…OCALA, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE... |
AIM announces Paul Goepfert, MD, as the principal investigator for th…AIM announces Paul Goepfert, MD, as the principal investigator for the... |
![]() FPL files details of new rate plan designed to power growing state wi…FPL files details of new rate plan designed to power growing state with... |
XPENG nomme Hedin Mobility Group comme distributeur et importateur po…XPENG nomme Hedin Mobility Group comme distributeur et importateur pour la... |
XPENG ernennt Hedin Mobility Group zum Vertriebspartner und Importeur…XPENG ernennt Hedin Mobility Group zum Vertriebspartner und Importeur für... |
New Survey Offers Detailed View of Short- and Long-Term Burden of Gui…New Survey Offers Detailed View of Short- and Long-Term Burden of... |
![]() HHRD Invites Donors to Join Their 20th Journey of Compassion This Ram…HHRD Invites Donors to Join Their 20th Journey of Compassion This... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions